ACC Highlights 2026

Program Access
Overview & Objectives
Program Materials
Funding Support

Click Here To Watch
Duration:	90 Minutes
Featuring:	Dr. Narendra Singh & Dr. Milan Gupta
Details:	N/A

Date

Apr 13, 2026

Time

90 minutes

Credits

Non-certified credits

Details

Navigate Using Individual Content Links

View Agenda

Description

This virtual program covered the key clinical trial findings and their implications from ACC 2026. This program is intended for cardiovascular specialists and primary care physicians.

Learning Objectives

Following participation in this program, participants will be able to:

Review trials and data presented at ACC 2026
Examine where the data presented may impact clinical practice guidelines
Apply the latest evidence-based strategies in clinical practice

Discussion Topics

CHAMPION-AF: How does left atrial appendage occlusion compare to anticoagulation in AF
SCOUT-HCM: Extending the benefits of mavacamten to adolescents with obstructive hypertrophic cardiomyopathy.
CORALreef Add-On: How does an oral PCSK9 inhibitor compare to ezetimibe, bempedoic acid, or their combination?
Ez-PAVE: Is achieving a target LDL-C of <1.4 superior to <1.8 in patients with ASCVD?
VESALIUS: Does evolocumab reduce events in patients with diabetes but without known atherosclerosis?

Faculty

Milan Gupta: MD, FRCPC, FCCS, CPC(HC)
Narendra Singh: MD, FRCPC, FCCS, FACC, FAHA

Program Chapter

Presenter

This program was developed by CCRN and has received unrestricted educational funding.

View Sponsorship Details

Program Slides: A copy of the program slides is available for purchase for CCRN members with a resource library subscription. View pricing and download options on the Resources Tab.

Back To Programs

Back To Main Programs

Sponsorship Details

Agenda

BECOME A CCRN MEMBER

Being a part of CCRN has benefits

Learn More